Visit Certara in Booth E5 at the DIA Europe 2026 in The Netherlands | March 24-26, 2026
サターラはライフサイエンス業界のイノベーターと連携することで、患者さんに医療を迅速に届けます。Together we advance modern drug development with biosimulation, regulatory science, and market access solutions. We use software, technology, and services to transform traditional drug discovery and development. Our clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries.
CoAuthor
Regulatory writing technology needs to be smarter, user-friendly, and collaborative—and CoAuthor delivers. It streamlines the process with fast template selection, structured content authoring, and generative AI within Microsoft Word.
Leverage a biomedically-specialized GPT behind your firewall, for secure, prompt-based text generation
GlobalSubmit eCTD Platform
GlobalSubmit enables teams to manage the regulatory process so they can successfully publish, validate, and review eCTD submissions across a global footprint of regulatory health authorities.
Create submissions that conform to health authorities’ required structure, XML, and validation report, including eCTD 4.0.
Identify and resolve compliance issues before submission, reducing rejection risks with a robust validation engine.
Streamlined Review Process across stakeholders with advanced navigation and annotation features.
